Organization
AnaCardio
1 clinical trial
Clinical trial
Randomized, Double-blind, Multiple Ascending Dose, Placebo-controlled, Safety, Tolerability, Efficacy, Pharmacokinetic (PK) and Pharmacodynamic (PD) Phase Ib/IIa Clinical Trial With AC01 in Patients With HFrEFStatus: Recruiting, Estimated PCD: 2025-06-30